Details
Stereochemistry | ACHIRAL |
Molecular Formula | O2 |
Molecular Weight | 31.9988 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=O
InChI
InChIKey=MYMOFIZGZYHOMD-UHFFFAOYSA-N
InChI=1S/O2/c1-2
Oxygen is a chemical element with atomic number 8. Diatomic oxygen constitutes 20.8% of the Earth's atmosphere. Diatomic oxygen is used by complex life forms such as animals, in cellular respiration. Medical oxygen is widely used in clinical practice to provide a basis for most modern anaesthetic techniques; to restore the tissue oxygen tension towards normal by improving oxygen availability in a wide range of conditions such as shock, severe haemorrhage, coronary occlusion, carbon monoxide poisoning, major trauma; to aid the resuscitation of the critically ill, when the circulation is impaired; to aid in neonatal resuscitation; to treat acute severe headache in adults diagnosed with cluster headache.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0009060 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24206183 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseNormobaric oxygen is widely recommended for patients with acute myocardial infarction. The randomized phase 3 clinical trial, however, did not demonstrate reduction in 1-year all-cause mortality compared to ambient air group. |
|||
Primary | Unknown Approved UseMedical oxygen is widely used in clinical practice to provide a basis for most modern anesthetic techniques; to restore the tissue oxygen tension towards normal by improving oxygen availability in a wide range of conditions such as shock, severe hemorrhage, coronary occlusion, carbon monoxide poisoning, major trauma. |
|||
Primary | Unknown Approved UseMedical oxygen is widely used in clinical practice to treat acute severe headache in adults diagnosed with a cluster headache. |
|||
Primary | Unknown Approved UseMedical oxygen is widely used in clinical practice to restore the tissue oxygen tension towards normal by improving oxygen availability in a wide range of conditions such as shock, severe hemorrhage, coronary occlusion, carbon monoxide poisoning, major trauma. |
PubMed
Title | Date | PubMed |
---|---|---|
Transcutaneous oxygen tension measurements in newborn infants. | 1975 Feb |
|
Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. | 1999 Dec |
|
VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. | 2000 Apr |
|
Redox regulation of p53 during hypoxia. | 2000 Aug 10 |
|
Tissue hypoxygenation activates the adrenomedullin system in vivo. | 2000 Feb |
|
Chinonin, a novel drug against cardiomyocyte apoptosis induced by hypoxia and reoxygenation. | 2000 Feb 21 |
|
Carcinogenic nickel induces genes involved with hypoxic stress. | 2000 Jan 1 |
|
Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure. | 2000 Mar |
|
Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. | 2000 May |
|
Bacterial translocation and tumor necrosis factor-alpha gene expression in experimental hemorrhagic shock. | 2000 Nov |
|
Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells. | 2000 Nov |
|
Neonatal mouse cardiac myocytes exhibit cardioprotection induced by hypoxic and pharmacologic preconditioning and by transgenic overexpression of human Cu/Zn superoxide dismutase. | 2000 Oct |
|
Regulation of diaphragmatic nitric oxide synthase expression during hypobaric hypoxia. | 2000 Sep |
|
Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. | 2000 Sep 16 |
|
Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation. | 2001 Aug |
|
Recovery from oxidant-mediated lung injury: response of metallothionein, MIP-2, and MCP-1 to nitrogen dioxide, oxygen, and ozone exposures. | 2001 Aug |
|
Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. | 2001 Aug 28 |
|
Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. | 2001 Dec 21 |
|
Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. | 2001 Jan 5 |
|
Hypoxia-induced regulation of MAPK phosphatase-1 as identified by subtractive suppression hybridization and cDNA microarray analysis. | 2001 Nov 30 |
|
Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. | 2001 Sep |
|
Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. | 2001 Sep |
|
Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. | 2002 Apr 1 |
|
The dietary flavonoid quercetin modulates HIF-1 alpha activity in endothelial cells. | 2002 Apr 26 |
|
Increased migration of murine keratinocytes under hypoxia is mediated by induction of urokinase plasminogen activator. | 2002 Dec |
|
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. | 2002 Dec |
|
Airway chemotransduction: from oxygen sensor to cellular effector. | 2002 Dec 15 |
|
Hypoxia and beta 2-agonists regulate cell surface expression of the epithelial sodium channel in native alveolar epithelial cells. | 2002 Dec 6 |
|
Adaptive responses to oxidative damage in three mutants of Caenorhabditis elegans (age-1, mev-1 and daf-16) that affect life span. | 2002 Nov |
|
Hyperbaric oxygen for cyclophosphamide-induced cystitis. | 2002 Nov |
|
The role of hypoxia-inducible signaling pathway in nickel carcinogenesis. | 2002 Oct |
|
Retinal oxygen: fundamental and clinical aspects. | 2003 Apr |
|
Suppression of tumor necrosis factor-alpha by beta2-adrenoceptor activation: role of mitogen-activated protein kinases in renal mesangial cells. | 2003 Jan |
|
Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). | 2003 Jul |
|
Redox regulation of HIF-1alpha levels and HO-1 expression in renal medullary interstitial cells. | 2003 Jun |
|
Hyperbaric oxygen for treating wounds: a systematic review of the literature. | 2003 Mar |
|
Oxygen administration in infants. | 2003 Mar |
|
The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha. | 2003 May |
Patents
Sample Use Guides
Medical oxygen is administered by inhalation through the lungs. The major exception is when a metered supply is fed into the oxygenator of an extracorporeal circulation of a cardiopulmonary by-pass system. For a cluster headache, oxygen should be administered as soon as possible after the onset of the attack, via a non-rebreathing facemask at a flow of 6 to 12 l/min for approximately 15 minutes.
Route of Administration:
Respiratory
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
10236-8
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
19211-2
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10248-3
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
JECFA EVALUATION |
INS-948
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10242-6
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10233-5
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
DSLD |
1363 (Number of products:4)
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10240-0
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
2703-7
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
WHO-VATC |
QV03AN01
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10245-9
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
WHO-ATC |
V03AN01
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
2705-2
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10239-2
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10235-0
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10244-2
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST | 1.1.1 | ||
|
LOINC |
10247-5
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10232-7
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
3147-6
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
3148-4
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10241-8
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST | 1.4 | ||
|
LOINC |
10238-4
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10234-3
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
11556-8
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10243-4
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
2706-0
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10226-9
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10237-6
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
3149-2
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
14864-3
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
NCI_THESAURUS |
C1940
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
DSLD |
1827 (Number of products:15)
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
28648-4
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
10246-7
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
2704-5
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
||
|
LOINC |
28649-2
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1234886
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
7782-44-7
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
100000090500
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
DTXSID2037681
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
7806
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | RxNorm | ||
|
m8333
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | Merck Index | ||
|
D010100
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
4235
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
OXYGEN
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | Description: A colourless gas; odourless. Solubility: One volume dissolves in about 32 volumes of water and in about 7 volumes of ethanol (~750 g/l) TS, both at apressure of 101.3 kPa and 20?C. Category: Gas for inhalation. Storage: Oxygen should be kept as compressed gas or liquid at cryogenic temperature, in appropriate containers complying withthe safety regulations of the national authority. Valves or taps should not be lubricated with oil or grease. Labelling: An ISO standard1 requires that cylinders containing oxygen intended for medical use should bear the name of thecontents in legible and permanent characters and, preferably, also the molecular formula O2.1 International Standard 32. Gas cylinders for medical use - marking for identification of content. International Organization for Standardization, Switzerland, 1977. Additional information: In the analysis of medicinal gases certain tests are not intended for hospital pharmacists. They are solely applicable by laboratories equipped with the specialized apparatus. Requirements: Oxygen contains not less than 99.5% v/v of O2. | ||
|
S88TT14065
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
S88TT14065
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
231-956-9
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
977
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
15379
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
C722
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
5054
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
25805
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
Triplet oxygen
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
SUB14733MIG
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY | |||
|
DB09140
Created by
admin on Fri Dec 15 16:12:45 GMT 2023 , Edited by admin on Fri Dec 15 16:12:45 GMT 2023
|
PRIMARY |
ACTIVE MOIETY